On the basis of these data, we hypothesized that the lack of hPRL in mouse hosts deprives xenografted human ER+ breast cancers of an essential endocrine factor that governs tumor engraftment, growth, metastasis, and drug responsiveness (29, 30). The gene discussed is PRLR; the disease is breast cancer.